Document is current
Any future updates will be listed below
-
Authors
Takahashi, Ippei
Murakami, Keiko
Kobayashi, Mika
Kikuchi, Saya
Igarashi, Ayaka
Obara, Taku
Ishikuro, Mami
Ueno, Fumihiko
Noda, Aoi
Onuma, Tomomi
Matsuzaki, Fumiko
Kobayashi, Natsuko
Hamada, Hirotaka
Iwama, Noriyuki
Saito, Masatoshi
Sugawara, Junichi
Tomita, Hiroaki
Yaegashi, Nobuo
Kure, Shigeo
Kuriyama, Shinichi
-
Funding
Funding for this research was provided by:
The Japan Agency for Medical Research and Development (JP20km0105001, JP21km0105002)
- License Information
-
More Information
Article History
Received: 1 March 2022
Accepted: 21 October 2022
First Online: 11 November 2022
Declarations
:
: The TMM BirThree Cohort Study protocol was reviewed and approved by the Ethics Committee of Tohoku University Tohoku Medical Megabank Organization (2013–1-103–1). The methods in this study have been carried out in accordance with the Declaration of Helsinki. All participants received explanations from trained genome medical research coordinators and provided written informed consent.
: Not applicable.
: KM is an Editorial Board Member for BMC Public Health. The other authors have no competing interests to declare.
